2020
DOI: 10.1002/tox.23080
|View full text |Cite
|
Sign up to set email alerts
|

Dieckol alleviates dextran sulfate sodium‐induced colitis via inhibition of inflammatory pathway and activation of Nrf2/HO‐1 signaling pathway

Abstract: Ulcerative colitis (UC) is the major type of inflammatory ailment with elevated prevalence worldwide. Dieckol (DEK) is a phlorotannin that is extensively found in marine algae and has been found to have different pharmacological properties. Nevertheless, the impact of DEK in UC has not been investigated earlier. Therefore, we appraised DEK's function in dextran sulfate sodium (DSS)‐induced UC in the mouse. An overall of 30 mice was randomized into 5 equal groups. Control mice treated with a standard diet (grou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 41 publications
0
12
0
Order By: Relevance
“…Given that activation of Nrf2/HO-1 signaling could alleviate the allergic responses associated with UC [ 32 , 33 ], we detected the expression of Nrf2 pathway-related genes in the colon tissue by RT-qPCR. According to the results ( Figure 9 ), colon Nrf2 mRNA expression significantly deteriorated in the UC model group to about 31% in comparison to the normal control group.…”
Section: Resultsmentioning
confidence: 99%
“…Given that activation of Nrf2/HO-1 signaling could alleviate the allergic responses associated with UC [ 32 , 33 ], we detected the expression of Nrf2 pathway-related genes in the colon tissue by RT-qPCR. According to the results ( Figure 9 ), colon Nrf2 mRNA expression significantly deteriorated in the UC model group to about 31% in comparison to the normal control group.…”
Section: Resultsmentioning
confidence: 99%
“…UC is a human IBD of unknown etiology, characterized mainly by intestinal inflammation and mucosal damage [2] . The current clinical treatment of UC mainly includes corticosteroids, aminosalicylates, sulfonamides, and immunosuppressive agents, but these drugs usually have serious side effects, which limit their clinical application [ 31 , 32 ] . Therefore, there is an urgent need to develop novel ingredients that have good preventive and therapeutic effects on UC with less side effects.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanical barrier shaped by using the shut connection between epithelial cells is of utmost significance (Liu et al, 2021). Nrf2 is a central regulator of keeping intracellular redox homeostasis and one of the key cytokines concerned with oxidative stress response, which can reply to exogenous harm and pathogen molecules (Arab et al, 2021; Zhang et al, 2021; Zhu et al, 2021). Keap1 is a negative regulator of Nrf2.…”
Section: Discussionmentioning
confidence: 99%